These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15592735)

  • 1. Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients.
    Dujardin K; Defebvre L; Duhamel A; Lecouffe P; Rogelet P; Steinling M; Destée A
    J Neurol; 2004 Nov; 251(11):1383-92. PubMed ID: 15592735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and neuropsychological features and changes to regional cerebral blood flow in ‍patients with Parkinson's disease dementia].
    Kuroha Y; Takahashi T; Arai Y; Yoshino M; Kasuga K; Hasegawa A; Matsubara N; Koike R; Ikeuchi T
    Rinsho Shinkeigaku; 2024 Sep; 64(9):623-631. PubMed ID: 39198159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive function and regional cerebral blood flow in Parkinson's disease.
    Jagust WJ; Reed BR; Martin EM; Eberling JL; Nelson-Abbott RA
    Brain; 1992 Apr; 115 ( Pt 2)():521-37. PubMed ID: 1606480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuropsychological and regional cerebral blood flow of posterior parietal area features in patients with Parkinson's disease with mild cognitive impairment].
    Kuroha Y; Takahashi T; Arai Y; Yoshino M; Kasuga K; Hasegawa A; Matsubara N; Koike R; Ikeuchi T
    Rinsho Shinkeigaku; 2022 Jul; 62(7):532-540. PubMed ID: 35753785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of cognitive function and regional cerebral blood flow in Parkinson's disease by 123I-IMP SPECT].
    Yamamoto K
    Rinsho Shinkeigaku; 1992 Jan; 32(1):1-7. PubMed ID: 1628430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain regions associated with cognitive impairment in patients with Parkinson disease: quantitative analysis of cerebral blood flow using 123I iodoamphetamine SPECT.
    Hattori N; Yabe I; Hirata K; Shiga T; Sakushima K; Tsuji-Akimoto S; Sasaki H; Tamaki N
    Clin Nucl Med; 2013 May; 38(5):315-20. PubMed ID: 23478846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of Parkinson's disease using 123I-IMP SPECT].
    Hayashi H; Odano I; Nishihara M; Higuchi S; Sakai K; Ishikawa A
    Kaku Igaku; 1989 Nov; 26(11):1405-15. PubMed ID: 2615027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
    Derejko M; Sławek J; Wieczorek D; Brockhuis B; Dubaniewicz M; Lass P
    Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of the cognitive function and the duration of the illness with the regional cerebral blood flow in the patients with Parkinson's disease: objective evaluation using stereotactic extraction estimation analysis in 123I-IMP SPECT].
    Sakai T; Kuzuhara S
    No To Shinkei; 2006 Jan; 58(1):29-37. PubMed ID: 16482919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease--a rCBF scintigraphy study.
    Wallin A; Ekberg S; Lind K; Milos V; Granérus AK; Granerus G
    Acta Neurol Scand; 2007 Dec; 116(6):347-54. PubMed ID: 17927803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-brain voxel-based correlation analysis between regional cerebral blood flow and intelligence quotient score in Parkinson's disease.
    Oishi K; Ogawa M; Oya Y; Kawai M
    Eur Neurol; 2004; 52(3):151-5. PubMed ID: 15492484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Sestini S; Scotto di Luzio A; Ammannati F; De Cristofaro MT; Passeri A; Martini S; Pupi A
    J Nucl Med; 2002 Jun; 43(6):725-32. PubMed ID: 12050315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia.
    Osaki Y; Morita Y; Fukumoto M; Akagi N; Yoshida S; Doi Y
    Mov Disord; 2005 Aug; 20(8):999-1005. PubMed ID: 15806567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT.
    Sestini S; Ramat S; Formiconi AR; Ammannati F; Sorbi S; Pupi A
    J Nucl Med; 2005 Sep; 46(9):1444-54. PubMed ID: 16157526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study.
    Hanyu H; Sato T; Hirao K; Kanetaka H; Iwamoto T; Koizumi K
    J Neurol Sci; 2010 Mar; 290(1-2):96-101. PubMed ID: 19931870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.
    Wakamori T; Agari T; Yasuhara T; Kameda M; Kondo A; Shinko A; Sasada S; Sasaki T; Furuta T; Date I
    Parkinsonism Relat Disord; 2014 Apr; 20(4):415-20. PubMed ID: 24467818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease.
    Imon Y; Matsuda H; Ogawa M; Kogure D; Sunohara N
    J Nucl Med; 1999 Oct; 40(10):1583-9. PubMed ID: 10520695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological functions and rCBF SPECT in Parkinson's disease patients considered candidates for deep brain stimulation.
    Paschali A; Messinis L; Lyros E; Constantoyannis C; Kefalopoulou Z; Lakiotis V; Papathanasopoulos P; Vassilakos P
    Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1851-8. PubMed ID: 19471923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial spin labeling reveals relationships between resting cerebral perfusion and motor learning in Parkinson's disease.
    Barzgari A; Sojkova J; Maritza Dowling N; Pozorski V; Okonkwo OC; Starks EJ; Oh J; Thiesen F; Wey A; Nicholas CR; Johnson S; Gallagher CL
    Brain Imaging Behav; 2019 Jun; 13(3):577-587. PubMed ID: 29744796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.